The challenge of prognostic markers in acute pancreatitis: internist's point of view.
Acute pancreatitis
Internal wards
Outcome
Prognostic factors
Score
Journal
Journal, genetic engineering & biotechnology
ISSN: 2090-5920
Titre abrégé: J Genet Eng Biotechnol
Pays: Netherlands
ID NLM: 101317150
Informations de publication
Date de publication:
25 May 2021
25 May 2021
Historique:
received:
12
09
2020
accepted:
10
05
2021
entrez:
26
5
2021
pubmed:
27
5
2021
medline:
27
5
2021
Statut:
epublish
Résumé
Acute pancreatitis, the most frequent hospitalization reason in internal medicine ward among gastrointestinal diseases, is burdened by high mortality rate. The disease manifests mainly in a mild form, but about 20-30% patients have a severe progress that requires intensive care. Patients presenting with acute pancreatitis should be clinically evaluated for organ failure signs and symptoms. Stratifying patients in the first days from symptoms onset is essential to determine therapy and care setting. The aim of our study is to evaluate prognostic factors for acute pancreatitis patients, hospitalized in internal medicine wards, and moreover, understanding the role of various prognostic scores validated in intensive care setting in predicting in-hospital mortality and/or admission to intensive care unit. We conducted a retrospective study enrolling all patients with diagnosis of acute pancreatitis admitted took an internal medicine ward between January 2013 and May 2019. Adverse outcome was considered in-hospital mortality and/or admission to intensive care unit. In total, 146 patients (137 with positive outcome and 9 with adverse outcome) were enrolled. The median age was (67.89 ± 16.44), with a slight prevalence of male (55.1%) compared to female (44.9%). C protein reactive (p = 0.02), creatinine (p = 0.01), sodium (p = 0.05), and troponin I (p = 0.013) after 48 h were significantly increased in patients with adverse outcome. In our study, progression in SOFA score independently increases the probability of adverse outcome in patients hospitalized with acute pancreatitis. SOFA score > 5 is highly predictive of in-hospital mortality (O.R. 32.00; C.I. 6.73-152.5; p = 0.001) compared to other scores. The use of an easy tool, validated in intensive care setting such as SOFA score, might help to better stratify the risk of in-hospital mortality and/or clinical worsening in patients hospitalized with acute pancreatitis in internal medicine ward.
Identifiants
pubmed: 34036463
doi: 10.1186/s43141-021-00178-3
pii: 10.1186/s43141-021-00178-3
pmc: PMC8149536
doi:
Types de publication
Journal Article
Langues
eng
Pagination
77Références
Gastroenterology. 2013 Jun;144(6):1272-81
pubmed: 23622137
N Z Med J. 2017 Feb 17;130(1450):55-68
pubmed: 28207725
Crit Care Med. 1999 Dec;27(12):2662-5
pubmed: 10628606
Clin Gastroenterol Hepatol. 2011 Aug;9(8):710-717.e1
pubmed: 21645639
Pancreatology. 2013 May-Jun;13(3):207-11
pubmed: 23719589
Clin Gastroenterol Hepatol. 2014 Jun;12(6):997-1002
pubmed: 24183957
Curr Gastroenterol Rep. 2010 Apr;12(2):83-90
pubmed: 20424979
Am J Med Sci. 2017 Feb;353(2):178-186
pubmed: 28183420
Curr Pharm Des. 2010;16(6):584-96
pubmed: 20388068
United European Gastroenterol J. 2018 Feb;6(1):63-72
pubmed: 29435315
Int J Mol Sci. 2020 Jan 04;21(1):
pubmed: 31947993
Nephrology (Carlton). 2015 Jul;20(7):485-91
pubmed: 25726708
Bratisl Lek Listy. 2013;114(3):166-71
pubmed: 23406186
Trends Mol Med. 2010 May;16(5):238-46
pubmed: 20444648
Antioxid Redox Signal. 2011 Nov 15;15(10):2683-98
pubmed: 21861696
Br J Surg. 1988 May;75(5):463-6
pubmed: 3390679
Am J Respir Crit Care Med. 1995 Nov;152(5 Pt 1):1527-33
pubmed: 7582288
Gastroenterol Rep (Oxf). 2014 Aug;2(3):226-31
pubmed: 24994834
Dtsch Med Wochenschr. 2021 Feb;146(4):229-236
pubmed: 33592658
Medicine (Baltimore). 2018 Feb;97(7):e9654
pubmed: 29443733
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013 Jun;157(2):105-13
pubmed: 23774848
J Biol Chem. 2013 May 10;288(19):13410-9
pubmed: 23530046
Lipids Health Dis. 2021 Feb 11;20(1):9
pubmed: 33573658
Gastroenterology Res. 2019 Apr;12(2):67-71
pubmed: 31019615
Am J Gastroenterol. 2011 Oct;106(10):1843-50
pubmed: 21876561
Dig Liver Dis. 2013 Apr;45(4):347-8
pubmed: 23122711
Gastroenterology. 2019 Jan;156(1):254-272.e11
pubmed: 30315778
Gastroenterol Res Pract. 2016;2016:1834256
pubmed: 27882045
J Gastroenterol Hepatol. 1999 Feb;14(2):168-71
pubmed: 10029299
Int J Inflam. 2012;2012:270319
pubmed: 22292125
Curr Treat Options Gastroenterol. 2019 Mar;17(1):146-160
pubmed: 30701454
FEBS Lett. 1989 Jan 2;242(2):237-9
pubmed: 2464504
Immunobiology. 2015 Oct;220(10):1161-9
pubmed: 26101138
Gut. 2008 Nov;57(11):1566-71
pubmed: 18625695
Clin Gastroenterol Hepatol. 2012 Jan;10(1):95-6; author reply 96
pubmed: 21888883
Gastroenterology. 2009 Sep;137(3):1083-92
pubmed: 19454288
Gut. 2000 Feb;46(2):239-43
pubmed: 10644319
Gastroenterology. 2018 Mar;154(4):1096-1101
pubmed: 29409760
Crit Care. 2007;11 Suppl 1:S1
pubmed: 18275590
Pancreas. 2012 Mar;41(2):271-7
pubmed: 21956639
Mech Ageing Dev. 2008 Jul-Aug;129(7-8):467-74
pubmed: 18502472
JAMA. 2016 Feb 23;315(8):762-74
pubmed: 26903335
JOP. 2005 Sep 10;6(5):438-44
pubmed: 16186665